SCHEMBL7325294

SCHEMBL7325294

NC(=O)c1c(-c2cccc(C(=O)O)c2)ccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.49
PLA2G2A P14555 1/20 0.48
DHODH Q02127 2/20 0.46
FOLH1 Q04609 2/20 0.45
MAPK1 P28482 1/20 0.44
MAP2K4 P45985 1/20 0.44
MAPKAPK3 Q16644 1/20 0.44
MAPK6 Q16659 1/20 0.44
SERPINE1 P05121 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
AXL P30530 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722165 0.85 BCAT2 (0.47) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL7787418 0.84 HDAC8 (0.43) DHODHFOLH1MAP2K4KMT2AMEN1
SCHEMBL7815771 0.81 MCL1 (0.60) KMOFOLH1MAPK1MAP2K4MAPKAPK3
SCHEMBL9053835 0.79 BCAT2 (0.49) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL7782141 0.77 HPGDS (0.47) MAPK1
SCHEMBL7782229 0.76 CAPN1 (0.51)
SCHEMBL7789876 0.76 DYRK1A (0.46) HPGD
SCHEMBL22005585 0.76 ALDH1A1 (0.47) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL28928988 0.76 MEN1 (0.46) MAPK1KMT2AMEN1KDM4EALDH1A1
SCHEMBL7789847 0.75 PPARG (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251917-B1 Benzamidoaldehydes and their use as cysteine protease inhibitors BASF AKTIENGESELLSCHAFT (DE) 2001-06-26 US disclosed
US-6103720-A ENZYME INHIBITORS; ANTIICHEMIC AND -TUMOR AGENTS; STROKES; ALZEIMER'S DISEASE BASF AKTIENGESELLSCHAFT (DE) 2000-08-15 US disclosed